WELCOME TO The government REPORT
Village Of Lakemoor
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
The Department of Homeland Security | May 29, 2020
Researchers in the Homeland Security Department’s Science and Technology Directorate recently produced and continue to update a predictive modeling tool that forecasts the natural decay of SARS-CoV-2—the virus that causes COVID-19—on surfaces under relevant temperature and humidity conditions. The SARS-CoV-2 Natural Decay Calculator pulls insights from in-progress research efforts conducted by S&T’s National Biodefense Analysis and Countermeasures Center. And while it...
Ping Identity | February 16, 2022
Ping Identity , the Intelligent Identity solution for the enterprise, today announced a distribution partnership with Carahsoft Technology Corp., The Trusted Government IT Solutions Provider®, to help U.S. Federal Government agencies modernize the nation's cybersecurity defenses with advanced identity, credential, and access management (ICAM) capabilities.
Under the agreement, Carahsoft will serve as Ping Identity's Master Government Aggregator®, making the company...
Axiologic Solutions | May 12, 2022
Axiologic Solutions LLC, a leader in federal IT solutions specializing in serving the nation’s national security and intelligence missions, announced it has acquired Tysons-based intelligence technology services firm Data Intelligence Technologies, which specializes in data science, cybersecurity and artificial intelligence. Data Intelligence Technologies is the second acquisition for Axiologic in less than 18 months, expanding the company’s customer base in the national security env...
Merck | December 22, 2021
Merck , known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that the United Kingdom Government will purchase an additional 1.75 million patient courses of molnupiravir (MK-4482), an investigational oral antiviral COVID-19 medicine. In the U.K., LAGEVRIO® is the planned trademark for molnupiravir; the trademark for molnupiravir in other countries has not been approved. With this additional procurement agreement, which follows a previously announced...
Emerging Technology, Government Business
Emerging Technology, Government Finance
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE